These findings provided evidence for the pathogenicity of the p.W785S mutation and contributed to understanding how TRPV4 mutations disrupt cellular signaling, ultimately leading to the development of SMDK. Here, TRPV4 is linked to spondylometaphyseal dysplasia, Kozlowski type.